Title: IMMUNOSUPPRESSION I:
1IMMUNOSUPPRESSION I
- Principles and Mechanisms of Current Agents
2Events Following T Cell Activation
0 0.5 1 2 24 hours. 3-4
days 7 days...
3The Phases of Immunosuppression
Chronic Allograft Dysfunction
Maintenance Immunosuppression
Graft Failure
4(No Transcript)
5Lymphocyte Depleting Antibody Therapies
CD52
CD3
6Daclizumab (Zenapax) and Basiliximab
(Simulect) Block the IL-2 Receptor
Antigen
APC
B7
CD4
CD28
IL-2R
1
2
Calcineurin
IL-2
IL - 2 gene
T Cell
7 Overview of Maintenance Immunosuppression
Costimulatory molecules i.e CD28 and CD40L
IL-2
IL-2R
b g
TCR complex ab TCR, CD3, CD4, etc
a CD25 (inducible)
SirolimusFKBP
Kinase activity
Apoptosis
Cyclosporinecyclophilin
Calmodulin
Calcineurin
TOR
De novo purine synthesis
Steroids
Phosphatase activity
G1
S
TacrolimusFKBP
NFAT AP-1 NF-KB
G2
IL-2 gene
M
Nucleus
Azathioprine
Mycophenolate Mofetil
8Corticosteroids-Molecular Mechanisms
IkB binds to NF-kB and prevents it from getting
into the nucleus and activating cytokine
transcription
Steroid
CELL
NF-kB
IkB
Steroid receptor
AP-1
X
IkB promoter
IL-2 promoter
NUCLEUS
9Cyclosporine and Tacrolimus Calcineurin
Inhibitors
10Azathioprine and Mycophenolate Mofetil
Costimulatory molecules i.e CD28 and CD40L
IL-2
IL-2R
b g
TCR complex ab TCR, CD3, CD4, etc
a CD25 (inducible)
Kinase activity
Apoptosis
Calmodulin
Calcineurin
TOR
De novo purine synthesis
Phosphatase activity
G1
S
NFAT AP-1 NF-KB
G2
IL-2 gene
M
Nucleus
Azathioprine
MycophenolateMofetil
11TOR Inhibitors (TORI) Sirolimus/Everolimus
Costimulatory molecules i.e CD28 and CD40L
IL-2
IL-2R
b g
TCR complex ab TCR, CD3, CD4, etc
a CD25 (inducible)
Kinase activity
TORIFKBP
Apoptosis
Calmodulin
Calcineurin
TOR
De novo purine synthesis
Phosphatase activity
G1
S
NFAT AP-1 NF-KB
G2
IL-2 gene
M
Nucleus
12US DeNovo Maintenance Regimensfor Kidney
Transplant Recipients
UNOS 11/02
13Outcomes of Renal Allografts
- Radiation
- Prednisone
- 6-MP
60 65 70 75 80 85 90 95 00
Year
Adapted from Stewart F, Organ Transplantation,
1999